Literature DB >> 10929050

Regulation of T-cell apoptosis: a mixed lymphocyte reaction model.

E O'Flaherty1, W K Wong, S J Pettit, K Seymour, S Ali, J A Kirby.   

Abstract

Despite the capacity for antigen-specific activation and rapid clonal expansion, homeostatic mechanisms ensure that the mature immune system contains a relatively stable number of T cells. In recent years, it has become apparent that this stability is a consequence of apoptotic death of most of the specific T cells generated during an immune response. Clearly this process must be tightly regulated in order to retain sufficient T-cell progeny to mediate an effective response, whilst allowing the rapid deletion of these cells at the end of the response to prevent lymphadenopathy and cross-reactive autoimmunity. In this study, the factors that regulate the sensitivity of T cells to apoptosis were investigated in vitro after the induction of primary T-cell activation within a mixed lymphocyte reaction (MLR). It was found that activated T cells rapidly acquire the expression of both Fas and Fas ligand (FasL) on their surface and contain high levels of the precursor form of the pro-apoptotic enzyme, caspase 8 (FLICE). However, these T cells were resistant for up to 5 days to apoptosis following the stimulation of Fas; a maximal apoptotic response was observed after 7 days. This time point coincided with a marked reduction in expression of the FLICE inhibitory protein (FLIP) and maximal activity of caspase 8. At time points beyond day 7, the number of viable cells in the MLR decreased further despite a reduction in the expression of FasL. However, the expression of interleukin-2 (IL-2) at these late time points was low, resulting in a decrease in expression of the anti-apoptotic protein Bcl-2. This can produce apoptosis by allowing leakage of cytochrome-c from mitochondria resulting in direct activation of the caspase cascade. In this study, it is shown that T cells are resistant to apoptosis for the first 5 days after activation as a consequence of insensitivity of the Fas pathway and the presence of intracellular Bcl-2. After between 5 and 7 days, the cells become sensitive to Fas-mediated apoptosis while retaining Bcl-2 expression. At later time points, Fas ligation is reduced but the cells respond to a decreased availability of IL-2 by reducing Bcl-2 expression; this encourages further apoptosis by allowing the direct activation of caspase enzymes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10929050      PMCID: PMC2327014          DOI: 10.1046/j.1365-2567.2000.00048.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

Authors:  T Brunner; R J Mogil; D LaFace; N J Yoo; A Mahboubi; F Echeverri; S J Martin; W R Force; D H Lynch; C F Ware
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

2.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors.

Authors:  M Thome; P Schneider; K Hofmann; H Fickenscher; E Meinl; F Neipel; C Mattmann; K Burns; J L Bodmer; M Schröter; C Scaffidi; P H Krammer; M E Peter; J Tschopp
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

3.  FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

Authors:  J P Medema; C Scaffidi; F C Kischkel; A Shevchenko; M Mann; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

4.  Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex.

Authors:  M E Peter; F C Kischkel; C G Scheuerpflug; J P Medema; K M Debatin; P H Krammer
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

Review 5.  Cellular environments and apoptosis: tissue microenvironments control activated T-cell death.

Authors:  A N Akbar; M Salmon
Journal:  Immunol Today       Date:  1997-02

6.  The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis.

Authors:  R M Kluck; E Bossy-Wetzel; D R Green; D D Newmeyer
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

Review 7.  IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2.

Authors:  J G Giri; D M Anderson; S Kumaki; L S Park; K H Grabstein; D Cosman
Journal:  J Leukoc Biol       Date:  1995-05       Impact factor: 4.962

8.  Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

Authors:  F Rieux-Laucat; F Le Deist; C Hivroz; I A Roberts; K M Debatin; A Fischer; J P de Villartay
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

Review 9.  Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model.

Authors:  G G Singer; A C Carrera; A Marshak-Rothstein; C Martínez; A K Abbas
Journal:  Curr Opin Immunol       Date:  1994-12       Impact factor: 7.486

Review 10.  Fas and the art of lymphocyte maintenance.

Authors:  M J Lenardo
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  11 in total

1.  Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.

Authors:  A Hartmann; J D Troadec; S Hunot; K Kikly; B A Faucheux; A Mouatt-Prigent; M Ruberg; Y Agid; E C Hirsch
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

2.  Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.

Authors:  Jerold Chun; Yasuyuki Kihara; Deepa Jonnalagadda; Victoria A Blaho
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

3.  Accelerating the induction of Fas-mediated T cell apoptosis: a strategy for transplant tolerance?

Authors:  H P Carroll; S Ali; J A Kirby
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null mice.

Authors:  Tsukasa Higuchi; Frank O Bartel; Masahiro Masuya; Takao Deguchi; Kelly W Henderson; Runzhao Li; Robin C Muise-Helmericks; Michael J Kern; Dennis K Watson; Demetri D Spyropoulos
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

5.  No evidence for apoptosis of decidual leucocytes in normal and molar pregnancy: implications for immune privilege.

Authors:  S Pongcharoen; J N Bulmer; R F Searle
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

6.  Secondary immunization inhibits drug induced apoptosisin vivo.

Authors:  Winston Costa Pereira; Muddanna S Rao; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2003-07

7.  Elimination of rheumatoid synovium in situ using a Fas ligand 'gene scalpel'.

Authors:  Haidi Zhang; Guangping Gao; Gilda Clayburne; H Ralph Schumacher
Journal:  Arthritis Res Ther       Date:  2005-09-08       Impact factor: 5.156

8.  AKAP9 regulates activation-induced retention of T lymphocytes at sites of inflammation.

Authors:  Jan M Herter; Nir Grabie; Xavier Cullere; Veronica Azcutia; Florencia Rosetti; Paul Bennett; Grit S Herter-Sprie; Wassim Elyaman; Francis W Luscinskas; Andrew H Lichtman; Tanya N Mayadas
Journal:  Nat Commun       Date:  2015-12-18       Impact factor: 14.919

9.  Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis Is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4.

Authors:  Xiaoqian Yu; Yuhua Wang; Jiang Lin; Yang Hu; Toshihisa Kawai; Martin A Taubman; Xiaozhe Han
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

10.  A novel noninvasive method to detect rejection after heart transplantation.

Authors:  Jun Hu; Xin Xie; Yuan Li; Shuang Wang; Qing Feng; Xin Wang; Daoyan Liang
Journal:  Braz J Med Biol Res       Date:  2012-10-16       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.